Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

    Sanja Javor, Donatella Bignardi, Matteo Borro, Cesare Massone
    29-08-2023
    https://doi.org/10.4081/dr.2023.9819
    1071
    PDF: 685
    HTML: 14
  • Unusual site presentation of dermatitis herpetiformis: line-field confocal optical coherence tomography for effective management

    Luca Bettolini, Stefano Bighetti, Sara Rovaris, Iacopo Ghini, Vincenzo Maione
    17-09-2025
    https://doi.org/10.4081/dr.2025.10100
    253
    PDF: 184
  • Keratoacanthoma centrifugum marginatum: unresponsive to oral retinoid and successfully treated with wide local excision.

    Kapildev Das, Nilay Kanti Das, Vikram Singh Rathore, Sourav Kundu, Sourav Choudhury, Ramesh Chandra Gharami, Pijush Kanti Datta
    e1
    18-01-2010
    https://doi.org/10.4081/dr.2010.e1
    8066
    PDF: 896
    HTML: 1560
  • Generalized bullous drug eruption triggered by ceftriaxone: a case report and literature overview

    Khuzama Alfalah, Khalid Nabil Nagshabandi, Hala Abdullah Almusa
    25-02-2025
    https://doi.org/10.4081/dr.2025.10208
    592
    PDF: 404
    HTML: 12
  • Rosacea: a clinical review

    Carsten Sauer Mikkelsen, Helene Ringe Holmgren, Petra Kjellman, Michael Heidenheim, Ari Karppinnen, Peter Bjerring, Theis Huldt-Nystrøm
    23-06-2016
    https://doi.org/10.4081/dr.2016.6387
    4277
    PDF: 2465
    HTML: 1257
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1305
    PDF: 405
    HTML: 45
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1057
    PDF: 561
    HTML: 73
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1077
    PDF: 717
    HTML: 56
  • Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

    Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen
    21-11-2022
    https://doi.org/10.4081/dr.2022.9469
    1302
    PDF: 548
    HTML: 33
  • Bullous pemphigoid with secondary acquired reactive perforating collagenosis: a challenging clinical case report

    Valentina Ruffo di Calabria, Elena Biancamaria Mariotti, Alberto Corrà, Alice Verdelli, Lavinia Quintarelli, Cristina Aimo, Giovanni Di Zenzo, Vincenza Maio, Daniela Massi, Marzia Caproni
    03-10-2024
    https://doi.org/10.4081/dr.2024.10087
    998
    PDF: 563
    HTML: 90
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    621
    PDF: 371
    HTML: 16
  • A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

    Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    06-06-2023
    https://doi.org/10.4081/dr.2023.9722
    789
    PDF: 460
    HTML: 17
  • Hyperimmunoglobulin E syndrome in two siblings

    Abdulmohti Hawilo, Ines Zaraa, Sondes Trojjet, Hella Zribi, Rym Cheikh Rouhou, Dalenda El Euch, Mourad Mokni, Amel Ben Osman
    e41
    28-11-2011
    https://doi.org/10.4081/dr.2011.e41
    1334
    PDF: 552
    HTML: 502
  • Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature

    Benedetta Sonego, Enrico Zelin, Iris Zalaudek, Nicola di Meo
    06-06-2023
    https://doi.org/10.4081/dr.2023.9676
    946
    PDF: 585
    HTML: 21
  • Acute generalized exanthematous pustulosis induced by iodinated contrast media: a case report

    Maisa Alfalah, Yara Alotaibi, Atheer Alotaibi, Raghad Alharthi
    08-05-2025
    https://doi.org/10.4081/dr.2025.10217
    417
    PDF: 224
    HTML: 10
  • Pityriasis following COVID-19 vaccinations: a systematic review

    Laura Duzett, Guadalupe Mercado, Vasiliki Tasouli-Drakou, Alicia Kane, Alison Tam
    09-08-2023
    https://doi.org/10.4081/dr.2023.9742
    1330
    PDF: 737
    Supplementary Material: 137
    HTML: 78
  • Purpuric pityriasis rosea in patients with anorexia nervosa

    Giulia Ciccarese, Antonio Guadagno, Astrid Herzum, Valentina Amicarelli, Francesco Drago
    20-01-2025
    https://doi.org/10.4081/dr.2025.10053
    392
    PDF: 235
    HTML: 13
  • A case of chronic ulcer due to subcutaneous arteriolosclerosis in an obese patient mimicking pyoderma gangrenosum

    Sezin Fıçıcıoğlu, Nuray Can, Busem Tutuğ
    14-05-2018
    https://doi.org/10.4081/dr.2018.7445
    1189
    PDF: 591
    HTML: 169
  • Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria)

    Mathieu Ziraldo, Ivan Theate, Olivier Vanhooteghem
    06-10-2021
    https://doi.org/10.4081/dr.2021.9358
    1549
    PDF: 572
    HTML: 874
26 - 44 of 44 items << < 1 2 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy